Novo Nordisk announces $11bn acquisition of fill-finish sites to boost global manufacturing
In a strategic move to enhance its global manufacturing capabilities, Novo Nordisk has announced a significant acquisition from Novo Holdings A/S, involving three fill-finish sites, in a deal worth $11 billion. This acquisition comes as part of a broader transaction where Novo Holdings A/S has agreed to acquire Catalent, Inc., a leading global contract development […]